Health News Releases

July 10, 10:40

First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders

Published today in Schizophrenia Bulletin (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1093%2Fschbul%2Fsbag082&esheet=54556765&newsitemid=20260618626815&lan=en-US&an

July 09, 13:55

WHOOP Names Dirk-Jan “DJ” van Hameren Chief Marketing Officer as Member Base Surpasses 3 Million

WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%2F%3Fsrsltid%3DAfmBOooOTY-AZkUZ-01Qee0dSrZN_xMoMokSbRiKqYhxdZZVXjMKa_-U&esheet=54566384&newsitemid=20260708877245

July 09, 09:00

Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations

Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy desi

July 08, 15:30

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

Biocytogen (SSE: 688796; HKEX: 02315) and Whitehawk Therapeutics, Inc. (“Whitehawk,” Nasdaq: WHWK) today announced a global collaboration to develop bispecific antibody-drug conjugates (BsADC). Biocyt

July 08, 11:00

Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status

July 08, 09:30

Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore

Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) s

July 07, 14:38

Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns

Galderma (SWX:GALD) has unveiled results from the world’s most extensive skin quality profiling survey, finding that skin quality concerns are widespread, can impact emotional wellbeing and, while dif

July 07, 11:20

Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe

Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (I

July 03, 10:30

Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member

Brenus Pharma, today announced key appointments to its board of directors. The company welcomes Eric DESSERTENNE, as President & Chairman of the board, succeeding co-founder Jacques GARDETTE, who will

July 02, 11:30

BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma

BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-311

July 01, 14:15

Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States

Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administra

July 01, 11:40

Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

For more than 35 years, Dos Santos has helped shape Medisca into a global leader in pharmaceutical compounding. As Chief Executive Officer, he will lead the company’s long-term strategy, with a focus

July 01, 10:15

Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against Harbour

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315) today announced that it has received a first-instance civil judgment from the Shanghai Intellectual Property Cou

June 30, 13:50

Cartilage Tissue Engineering Heads to Orbit in NSF and NASA-supported Study at the International Space Station

Researchers in the DELTAi Lab at the University of California, Irvine (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fsites.uci.edu%2Fdeltai%2F&esheet=54561327&newsitemid=2026062954

June 29, 09:34

DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion followin

June 28, 14:55

Burjeel Holdings Prices First MENA Healthcare Sukuk Since 2018, 3.2x Oversubscribed

The offering attracted significant demand from high-quality international and regional investors, with the orderbook peaking at USD 1.6 billion, representing 3.2x oversubscription. The strength of the

June 26, 11:30

MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b

MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, today announced the appointment of two experienced industry leaders to its Board of Directors a

June 24, 16:32

Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO

In the final step of its 18-month CEO transition, Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&eshee

June 24, 08:51

Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies

Merck, a leading global science and technology company, today announced a strategic research-stage collaboration with Saturnus Bio, a Versant Ventures-founded biotech, aimed at establishing a foundati

June 23, 11:30

HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors

HistoSonics (https://histosonics.com/?utm_source=chatgpt.com), the developer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the closing of a new financing r

June 22, 14:00

CellFiber to Co-Host Next-Generation Stem Cell Manufacturing and Commercialization Workshop with Cytiva in Korea

CellFiber will jointly host the Next-Generation Stem Cell Manufacturing and Commercialization Strategy Workshop with Cytiva on Wednesday, 15 July 2026 at the Cytiva APAC Fast Trak™ Center in Songdo, I

June 19, 11:01

Astrogen, inc. Validates Autism Spectrum Disorder Research with Prestigious Folia Award

Astrogen, inc. (https://astrogen.co.kr/eng/index.html), a leading biotech company in South Korea, said that it has received the “Folia Award (https://onlinelibrary.wiley.com/doi/toc/10.1111/) (ISSN)14

June 17, 15:55

BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit

BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chro

June 17, 11:30

Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery

Biocytogen today announced that its Boston research facility has been awarded Full Accreditation by AAALAC International, a globally recognized organization dedicated to promoting excellence in labora

June 16, 16:55

New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54552126&newsitemid=20260615651327&lan=en-US&ancho

News by Region

News by Industry